SCHEMBL26558192

SCHEMBL26558192

COc1ccc(CNC(=O)Nc2ccc(CN3CCN(C)CC3)cc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.64
NPC1 O15118 2/20 0.62
RAB9A P51151 2/20 0.62
HDAC1 Q13547 1/20 0.59
HDAC6 Q9UBN7 1/20 0.59
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
HTT P42858 1/20 0.57
FAAH O00519 2/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
PKM P14618 1/20 0.56
POLB P06746 1/20 0.56
MCHR1 Q99705 2/20 0.56
CHRM1 P11229 1/20 0.56
HTR2A P28223 1/20 0.56
RXFP1 Q9HBX9 1/20 0.55
TSHR P16473 1/20 0.55
HIF1A Q16665 1/20 0.55
EPAS1 Q99814 1/20 0.55
HRH3 Q9Y5N1 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26547393 0.91 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL26099890 0.90 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747448 0.89 CHRM1 (0.69) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747572 0.89 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747569 0.89 PKM (0.72) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL26547235 0.88 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL26547223 0.88 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23747488 0.87 TSHR (0.72) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL26101691 0.87 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9AHDAC1HDAC6
SCHEMBL23727641 0.87 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9AHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 SMN1; SMN2 1161/4885NPC1 463/4885RAB9A 807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.